Fundraising Fox

Camp4

Founded 2016 · 62 employees on LinkedIn · 3 known investors

Camp4 is a biotechnology company focused on genetic research and neurology, leveraging expertise in genomics and neuroscience for therapeutic development.

Also known as CAMP4 Therapeutics

AI & Machine LearningBiotech

Founders & leadership

Board

CW
Christopher Walsh, MD, PhDScientific Advisor

Investors · 3

5AM VenturesBoston · $100K – $4M
Andreessen HorowitzMenlo Park · $500K – $50M
Flucas VenturesJupiter · $100K – $5Mvia Ashley Flucas · inferred

Funding

SEC filings, press & company announcements

Source: company announcements and press reports — follow each round's link for the claim.

Company profile

researched Aug 2026

CAMP4 Therapeutics is a biotechnology company developing a class of RNA medicines intended to increase expression of targeted genes. Its approach uses antisense oligonucleotide (ASO) therapeutics designed to selectively upregulate gene expression by modulating regulatory RNA, with the stated aim of addressing the underlying cause of protein deficiency. The company frames inadequate gene expression as the root cause of more than a thousand diseases.

The company is advancing a pipeline of first-in-class ASO-based therapeutics aimed at diseases characterized by insufficient protein expression, and targets disease areas where patient communities have limited or no treatment options. Its leadership team is described as having expertise in RNA biology and drug development.

▸Full profile — market position, technology, go-to-market

Market position

Positions itself as pioneering a new class of RNA medicines focused on increasing, rather than reducing, targeted gene expression.

Differentiates on selective upregulation of gene expression through modulation of regulatory RNA with ASOs, addressing protein deficiency directly with stated precision and control.

Technology

The core technology is antisense oligonucleotide (ASO) therapeutics that modulate regulatory RNA in order to selectively upregulate expression of a target gene, increasing production of a deficient protein rather than silencing or replacing a gene.

Go-to-market

Patient populations with diseases caused by insufficient gene or protein expression, including disease areas with limited to no available treatment options.

Compiled by commissioned research from 1 cited public sources — announcements, filings, and press listed under research sources below.

Key figures

latest reported
HeadcountAug 202662

Company-reported or press-reported figures, each dated to when it was claimed — not independently audited.

Competitors · 7

by search overlap
Robinhood16 shared keywordsRobinhood is a financial trading platform that enables users to manage portfolios across stocks, ETFs, cryptocurrencies, options, futures, and prediction markets. The platform serves retail investors with low barriers to entry, offering portfolio management services and market insights.
TradingView16 shared keywordsTradingView is a charting platform and social network used by over 100 million traders and investors worldwide to analyze and trade across global financial markets. The platform provides tools for technical analysis, market data, and community collaboration for retail and institutional traders.
Public14 shared keywordsPublic is a trading platform that allows users to buy and sell cryptocurrencies including Bitcoin, Ethereum, and memecoins through accounts managed by Zero Hash LLC, a New York State-licensed virtual currency business.
Simply Wall St14 shared keywordsSimply Wall St is an investment platform that provides financial data visualization and analysis tools for individual investors. The platform serves long-term investors globally by simplifying complex market information into visual and narrative formats to make stock investing more accessible.
Prior Finance13 shared keywordsPrior Finance operates a digital financial services platform offering personal loans, student loans, home loans, deposit accounts, credit cards, and investment tools through an integrated mobile application, serving both individual members and enterprise partners seeking lending solutions and technology infrastructure.
StockTwits13 shared keywordsStocktwits operates an online community platform where investors and traders share ideas, analysis, and trade discussions organized around stock tickers. The page presented is its community guidelines rather than a product description.
Seeking Alpha12 shared keywordsSeeking Alpha is a financial research platform offering stock analysis, market news, investment ideas, and quantitative ratings across asset classes, drawing on a large community of contributing analysts. It serves individual and professional investors seeking research and data-driven insight on stocks and markets.

Companies competing with Camp4 for the same Google search keywords, organic and paid, via search-intersection analysis.

In the news

We Think Camp4 Therapeutics (NASDAQ:CAMP) Can Afford To Drive Business Growth - Simply Wall St Newssimplywall.st · Jul 2026Camp4 Raises $100M in Series B Financingfinsmes.com · Jul 2022

▸Research sources · 1

primary sources listed

1 public sources were cited for this profile; the first-party ones are listed here.

Frequently asked questions

What does Camp4 do?
CAMP4 Therapeutics develops antisense oligonucleotide RNA medicines designed to increase targeted gene expression.
Who are Camp4's investors?
Camp4's investors include 5AM Ventures, Andreessen Horowitz, Flucas Ventures.